Ameritas Investment Company’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Ameritas Investment Company’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$539K	Buy	+11,369	New	+$565K	0.02%	399
2021 Q2	–	Sell	-246	Closed	-$12.4K	–	2104
2021 Q1	$12.4K	Buy	+246	New	+$13.1K	﹤0.01%	1449
2019 Q1	–	Sell	-362	Closed	-$13K	–	1793
2018 Q4	$13K	Buy	+362	New	+$15.4K	﹤0.01%	981

Other funds holding XPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Ameritas Investment Company's XPH Position: Q3 2021 in Review

Ameritas Investment Company opened a new position in State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2021: 11,369 shares worth $539K. The stake represents 0.02% of the portfolio and ranks #399 among its holdings. This is a return to the name: Ameritas Investment Company previously reported a position in XPH as recently as Q1 2021.

Ameritas Investment Company first reported a position in XPH in Q4 2018 and has held it in 3 quarters since. 78 funds tracked by Wall St. Rank hold XPH as of Q3 2021.

Ameritas Investment Company held 11,369 shares of State Street SPDR S&P Pharmaceuticals ETF worth $539K as of Q3 2021.
State Street SPDR S&P Pharmaceuticals ETF was a new Ameritas Investment Company position in Q3 2021.
State Street SPDR S&P Pharmaceuticals ETF made up 0.02% of Ameritas Investment Company's portfolio in Q3 2021, its #399 holding.
Ameritas Investment Company first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2018 and has held it in 3 quarters since.
78 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2021.

Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.